Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories

The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Science in Action has confirmed that it has received ethics approval for an in vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT) (the "Study"). Both Entheon and Science in Action have applied for requisite permits in order to export, receive and research DMT drug product.

By |2021-02-22T23:05:28-08:00February 22, 2021|DMT, Psychedelic News, Studies|0 Comments

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

N,N-Dimethyltryptamine, or DMT, is a hallucinogenic tryptamine drug producing effects similar to those of other psychedelics like LSD, ketamine, psilocybin and psilocin. DMT occurs naturally in many plant species and animals and has been used in religious ceremonies as a traditional spiritual medicine by indigenous people in the Amazonian basin. DMT can also be synthesised in a laboratory.

By |2021-02-20T01:02:20-08:00February 20, 2021|Articles & News, DMT|0 Comments

California Would Legalize Possession Of Psychedelics Like LSD, DMT And Psilocybin Under New Senate Bill

Possession of psychedelics such as psilocybin mushrooms, LSD and DMT would be legalized in California under a new Senate bill that was introduced on Wednesday.

The Most Psychedelic Friendly Countries in the World

The use of psychedelics, especially naturally-occurring ones, dates back centuries. History has it that many of them served various traditional and healing purposes among the indigenous people in different parts of the world. However, their healing qualities have had a checkered past. This is now changing.

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

– MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties.

By |2021-02-11T19:20:25-08:00February 11, 2021|Articles & News, DMT|0 Comments

Here’s How Psychedelic Therapy & Psilocybin In Canada Is Changing Lives

It took decades for the cannabis to become legal for recreational use and there does not seem to be a time in the near future that you can just walk into a dispensary and purchase magic mushrooms in the same way as you would marijuana, but thanks to the tireless work of some advocates for psychedelic-assisted psychotherapy, psilocybin could be legal for medical use soon.

The Case for Mass Producing Psychedelic Pharmaceuticals

In this article, financial journalist Marc Davis discusses the mass [...]

Go to Top